FDA Inspection 1090660 — Innovative Blood Resources

Innovative Blood Resources — FEI 2177724

The FDA completed an inspection of Innovative Blood Resources on May 1, 2019 in Duluth, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 1, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Duluth, MN (United States)